Barclays Reports 18 Profit Increase Upgrades FullYear Income Guidance US Stock Futures and Bond Yields Decline Amid Reports of Putins Updated Nuclear Doctrine ZeroDown Mortgages Can Buyers Truly Purchase a Home Without a Down Payment Telecom CEO Warns Europe Remains Vulnerable to US Satellite and AI Dominance Zydus Lifesciences Boosts Share Buyback Price to Rs 1260 Reduces Repurchase Size Tesla Launches Full SelfDriving Supervised in China Amidst Stiff Local Competition SWKHL Q3 2025 Earnings Strong EPS Beat of 70 Delivers 59 Cents Per Share AII Q1 2026 Earnings Earnings Beat Expectations Amid Strong Underwriting Performance GRBK Q1 2026 Earnings EPS Surges 15 Above Estimates DTE Q1 2026 Earnings EPS Misses Estimates Amid Regulatory and Operational Headwinds CRCT Q1 2026 Earnings EPS Surges Past Estimates with 145 Beat TAYD Q1 2026 Earnings EPS Slightly Above Estimates Amid Strong Operational Performance FG Imperii Acquisition Corp FGII Holds Steady Near Support as SPAC Market Watches for Catalysts NextTrip Inc NTRP Gains 65 as Shares Bounce from Support Level Carlyle Credit Income Fund Series D Preferred Shares CCID Hold Steady at 2535 Super League Enterprise Plunges 11 as Bears Take Control Below 463 Resistance Marathon Bancorp Inc MBBC Posts Strong Gains Approaches Resistance Level Amazon Reports Record Thanksgiving Holiday Sales and Item Volumes Ballard Power Systems BLDP Q1 2026 Earnings Narrowing Loss Beats Estimates Shares Edge Higher Ribbon Communications RBBN Surges 528 as Shares Test Key Resistance Level Ormat Technologies Q1 2026 Earnings EPS Surges 403 Above Estimates Stock Slips Once Upon a Farm PBC OFRM Q1 2026 Earnings EPS Misses Estimates Stock Gains Amid Uncertainty LAR Q1 2026 Earnings EPS Misses Estimates Amid Lithium Market Headwinds STKS Q1 2026 Earnings WiderthanExpected Loss as EPS Misses Estimates Significantly Genworth Financial Q1 2026 Earnings EPS Misses Estimates by Over 40 Stock Declines EBF Q1 2026 Earnings EPS Misses Estimates Amid Industry Headwinds QURE Q1 2026 Earnings NarrowerthanExpected Loss as Gene Therapy Developer Continues Pipeline Progress